cell 620 words KG: DAM
Contents

Disease-Associated Microglia (DAM)

🧫 Cell Type Info
Cell TypeDAM
Associated DiseasesNeurodegenerative Diseases, Alzheimer's Disease, NEURODEGENERATION, ALZHEIMERS
Related GenesAMYLOID, APOE
Linked Hypotheses127 hypotheses

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (28)

ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.87
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.79
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76
Targeted Butyrate Supplementation for Microglial Phenotype M
Score: 0.70
Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.68
Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.66
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
TREM2-mediated microglial tau clearance enhancement
Score: 0.62
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
APOE Isoform Expression Across Glial Subtypes
Score: 0.74
Senescent Cell Mitochondrial DNA Release
Score: 0.74
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
APOE-TREM2 Interaction Modulation
Score: 0.74
Senescence-Associated Myelin Lipid Remodeling
Score: 0.73
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.73
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.72
pg 1/2Next →

Related Analyses (28)

Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · completed
Neuroinflammation and microglial priming in early Alzheimer'
neurodegeneration · archived
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · completed
Microglial subtypes in neurodegeneration — friend vs foe
neuroscience · archived

Related Experiments (7)

Microglial Aging and Immune Memory in Neurodegeneration — Tr
validation · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.45
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.45
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.45
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40

See Also (5)

Neurodegeneration
disease · KG edge: associated_with
Microglia in Neurodegeneration
entity · KG edge: associated_with
TREM2 Protein (Triggering Receptor Expressed on Myeloid
entity · KG edge: activates
APOE contributes to Alzheimer's disease by regulating b
hypothesis · KG edge: interacts_with
CNS Drug Delivery Methods
mechanism · KG edge: expressed_in

Knowledge Graph (12 edges)

TREM2 activates DAM
DAM associated_with NEURODEGENERATION
DAM expressed_in CNS
DAM associated_with ALZHEIMERS
DAM interacts_with APOE
DAM associated_with microglia
TREM2 drives DAM
DAM protects_against Neurodegeneration
DAM mediates Amyloid-Beta Phagocytosis
DAM involved_in Phagocytosis

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.